LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

Search

23andMe Holding Co (Class A)

Gesloten

0.6

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

0.59

Max

0.67

Technische score

By Trading Central

Vertrouwen

Strong Bearish Evidence

23andMe Holding Co (Class A) Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

19 mei 2025, 11:55 UTC

Acquisities, Fusies, Overnames

Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million

13 jun 2025, 21:42 UTC

Acquisities, Fusies, Overnames

Anne Wojcicki Wins Bidding for 23andMe -- 2nd Update

13 jun 2025, 20:45 UTC

Acquisities, Fusies, Overnames

23andMe: TTAM Makes Binding Commitments for Additional Consumer Protections and Privacy Safeguards

13 jun 2025, 20:34 UTC

Acquisities, Fusies, Overnames

Anne Wojcicki Wins Bidding for 23andMe -- Update

13 jun 2025, 20:14 UTC

Acquisities, Fusies, Overnames

Nonprofit Controlled By 23andMe Co-Founder Anne Wojcicki Would Buy the DNA-Testing Company for $305 Million -- WSJ

13 jun 2025, 20:14 UTC

Acquisities, Fusies, Overnames

Anne Wojcicki Wins Bidding for 23andMe -- WSJ

13 jun 2025, 20:14 UTC

Acquisities, Fusies, Overnames

Regeneron Walks Away From 23andMe Acquisition After Wojcicki's Higher Bid -- WSJ

5 jun 2025, 01:41 UTC

Acquisities, Fusies, Overnames

23andMe's Former CEO Pushes Purchase Price Nearly $50 Million Higher -- WSJ

19 mei 2025, 17:52 UTC

Top Nieuws
Acquisities, Fusies, Overnames

Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million -- 2nd Update

19 mei 2025, 16:13 UTC

Acquisities, Fusies, Overnames

Regeneron Is Buying 23andMe. The Deal Is a Head Scratcher. -- Barrons.com

19 mei 2025, 14:42 UTC

Top Nieuws
Acquisities, Fusies, Overnames

Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million -- 2nd Update

19 mei 2025, 13:33 UTC

Top Nieuws
Acquisities, Fusies, Overnames

Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million -- Update

19 mei 2025, 11:10 UTC

Acquisities, Fusies, Overnames

Regeneron: To Ensure Compliance With 23andMe Consumer Privacy Policies, Applicable Laws on Customer Data >REGN

19 mei 2025, 11:10 UTC

Acquisities, Fusies, Overnames

Regeneron: 23andMe Transaction Expected to Close in 3Q >REGN

19 mei 2025, 11:09 UTC

Acquisities, Fusies, Overnames

Regeneron: To Continue All 23andMe Consumer Genome Services Uninterrupted >REGN

19 mei 2025, 11:08 UTC

Acquisities, Fusies, Overnames

Regeneron: Named Successful Bidder in Bankruptcy Auction for Substantially All Assets of 23andMe >REGN

Peer Vergelijking

Prijswijziging

23andMe Holding Co (Class A) Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Technische score

By Trading Central

4.88 / 4.91Steun & Weerstand

Korte Termijn

Strong Bearish Evidence

Gemiddeld Termijn

Strong Bearish Evidence

Lange Termijn

No Evidence

Financieel

$